127 related articles for article (PubMed ID: 26754093)
1. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India.
Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA
Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093
[TBL] [Abstract][Full Text] [Related]
2. PTEN Genetic and Epigenetic Alterations Define Distinct Subgroups in North Indian Breast Cancer Patients.
Kazim Z; Wahabi K; Perwez A; Lal P; Rizvi MA
Asian Pac J Cancer Prev; 2019 Jan; 20(1):269-276. PubMed ID: 30678449
[TBL] [Abstract][Full Text] [Related]
3. Altered transcription and expression of PTEN in breast tumors: is it regulated by hypermethylation?
Shetty PJ; Pasupuleti N; Chava S; Nasaruddin K; Hasan Q
Breast Dis; 2011; 33(1):27-33. PubMed ID: 21846942
[TBL] [Abstract][Full Text] [Related]
4. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
5. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation.
Sadeq V; Isar N; Manoochehr T
Med Oncol; 2011 Jun; 28(2):420-3. PubMed ID: 20237868
[TBL] [Abstract][Full Text] [Related]
6. PTEN promoter is methylated in a proportion of invasive breast cancers.
Khan S; Kumagai T; Vora J; Bose N; Sehgal I; Koeffler PH; Bose S
Int J Cancer; 2004 Nov; 112(3):407-10. PubMed ID: 15382065
[TBL] [Abstract][Full Text] [Related]
7. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
[TBL] [Abstract][Full Text] [Related]
8. Assessment of epigenetic alterations and in silico analysis of mutation affecting PTEN expression among Indian cervical cancer patients.
Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Bin Hafeez Z; Tiwari RR; Wahabi K; Gandhi G; Alam Rizvi MM
J Cell Biochem; 2019 Sep; 120(9):15851-15866. PubMed ID: 31074114
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
[TBL] [Abstract][Full Text] [Related]
10. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran.
Yari K; Payandeh M; Rahimi Z
Tumour Biol; 2016 Jun; 37(6):8145-52. PubMed ID: 26715274
[TBL] [Abstract][Full Text] [Related]
11. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population.
Rizvi MM; Alam MS; Ali A; Mehdi SJ; Batra S; Mandal AK
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1255-62. PubMed ID: 21698421
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
[TBL] [Abstract][Full Text] [Related]
14. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K
Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
17. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
[TBL] [Abstract][Full Text] [Related]
18. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
[TBL] [Abstract][Full Text] [Related]
19. Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.
Chattopadhyay S; Deo SV; Shukla NK; Husain SA
Tumour Biol; 2014 Aug; 35(8):7911-9. PubMed ID: 24833090
[TBL] [Abstract][Full Text] [Related]
20. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
